References :
[1] Tanenbaum, R.E., Galor, A., Dubovy, S.R. et al. Classification,
diagnosis, and management of conjunctivallymphoma. Eye and Vis 6, 22
(2019).
[2] Sjö LD. Ophthalmic lymphoma: epidemiology and pathogenesis. Acta
Ophthalmol 2009;87 Thesis 1(Thesis 1):1–20.
[3] Al-Muammar A, Hodge WG, Farmer J. Conjunctival T-cell Lymphoma:
A Clinicopathologic Case Report. Ophthalmology 2006; 113: 459-61.
[4] Kirkegaard MM, Coupland SE, Prause JU, Heegaard S. Malignant
lymphoma of the conjunctiva. Surv Ophthalmol. 2015;60(5):444–58.
[5] Chen YJ, Chen JT, Lu DW, Gao HW, Tai MC. Primary Peripheral
T-Cell Lymphoma of the Orbit. Arch Ophthalmol. 2009;127:1070.
[6] Janatpour KA, Choo PH, Lloyd WC. Primary orbital peripheral
T-celllymphoma: histologic, immunophenotypic, and genotypic features.
Arch Ophthalmol. 2007;125:1289–92. (Chicago, Ill. 1960).
[7] Al-Muammar A, Hodge WG, Farmer J. Conjunctival T-cellLymphoma: A
Clinicopathologic Case Report. Ophthalmology 2006; 113: 459-61.
[8] Lee DS, Woo KI, Chang HR. T-cell lymphoma presenting as painful
ophthalmoplegia. Korean J Ophthalmol. 2006;20:192–4.
[9] Coupland SE, Foss HD, Assaf C, Auw-Haedrich C, Anastassiou G,
Anagnostopoulos I, Hummel M, Karesh JW, Lee WR, Stein H. T-cell and T/
natural killer-cell lymphomas involving ocular and ocular adnexal
tissues: aclinicopathologic, immunohistochemical, and molecular study of
seven cases. Ophthalmology. 1999;106:2109–20.
[10] Shields, C.L.; Chien, J.L.; Surakiatchanukul, T.; Sioufi, K.;
Lally, S.E.; Shields, J.A. Conjunctival Tumors: Review of Clinical
Features, Risks, Biomarkers, and Outcomes—The 2017 J. Donald M. Gass
Lecture. Asia Pac. J. Ophthalmol. (Phila) 2017, 6, 109–120.
[11] Kirkegaard MM, Coupland SE, Prause JU, Heegaard S. Malignant
lymphoma of the conjunctiva. Surv Ophthalmol. 2015;60(5):444-458